Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Facioscapulohumeral Muscular Dystrophy.

Continuum (Minneapolis, Minn.) - 1 Dec 2022

Mul Karlien

Abstract excerpt

PURPOSE OF REVIEW: This article reviews the current knowledge on the clinical characteristics and disease mechanism of facioscapulohumeral muscular dystrophy (FSHD), as well as advances in targeted therapy development. RECENT FINDINGS: FSHD has a wide range of severity, yet a distinct phenotype characterized by weakness of the facial, shoulder, and upper arm muscles, followed by weakness of the trunk and leg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cardiomyopathy and Myosin Studies
Share to Muscle Physiology and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscle, Skeletal

Share to Muscular Dystrophy, Facioscapulohumeral

Share to Neurogenetic and Muscular Disorders Research

Share to Phenotype

Source

Identifiers

PMID: 36537978
DOI: 10.1212/CON.0000000000001155

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Facioscapulohumeral Muscular Dystrophy.PMID 36537978Read ↗

Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible TreatmentsSemantic proximity Read ↗

Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings.Semantic proximity Read ↗

Facioscapulohumeral Muscular DystrophySemantic proximity Read ↗

Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscleSemantic proximity Read ↗

Facioscapulohumeral Dystrophy: Molecular Basis and Therapeutic Opportunities.Semantic proximity Read ↗

A Pediatric Review of Facioscapulohumeral Muscular DystrophySemantic proximity Read ↗

Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an updateSemantic proximity Read ↗

Integrating clinical and genetic observations in facioscapulohumeral muscular dystrophy.Semantic proximity Read ↗

Facioscapulohumeral dystrophy: the path to consensus on pathophysiologySemantic proximity Read ↗

Genetic Approaches for the Treatment of Facioscapulohumeral Muscular DystrophySemantic proximity Read ↗

Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical LandscapeSemantic proximity Read ↗

Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.